Bliss GVS Pharma Limited

NSEI:BLISSGVS Stock Report

Market Cap: ₹12.8b

Bliss GVS Pharma Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Gagan Sharma

Chief executive officer

₹18.0m

Total compensation

CEO salary percentage100.0%
CEO tenure2.9yrs
CEO ownershipn/a
Management average tenure2.9yrs
Board average tenure10.3yrs

Recent management updates

Recent updates

Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Right But Growth Is Lacking

Apr 27
Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Right But Growth Is Lacking

Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?

Feb 20
Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?

There Is A Reason Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Undemanding

Jan 26
There Is A Reason Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Undemanding

Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?

Jul 14
Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?

Bliss GVS Pharma (NSE:BLISSGVS) Has Affirmed Its Dividend Of ₹0.50

Sep 11
Bliss GVS Pharma (NSE:BLISSGVS) Has Affirmed Its Dividend Of ₹0.50

Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50

Aug 28
Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50

These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well

May 21
These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well

Estimating The Intrinsic Value Of Bliss GVS Pharma Limited (NSE:BLISSGVS)

Apr 08
Estimating The Intrinsic Value Of Bliss GVS Pharma Limited (NSE:BLISSGVS)

A Look At Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Returns

Mar 18
A Look At Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Returns

Here's How We Evaluate Bliss GVS Pharma Limited's (NSE:BLISSGVS) Dividend

Feb 25
Here's How We Evaluate Bliss GVS Pharma Limited's (NSE:BLISSGVS) Dividend

Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet

Feb 08
Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet

What Type Of Shareholders Make Up Bliss GVS Pharma Limited's (NSE:BLISSGVS) Share Registry?

Jan 21
What Type Of Shareholders Make Up Bliss GVS Pharma Limited's (NSE:BLISSGVS) Share Registry?

Do Its Financials Have Any Role To Play In Driving Bliss GVS Pharma Limited's (NSE:BLISSGVS) Stock Up Recently?

Jan 08
Do Its Financials Have Any Role To Play In Driving Bliss GVS Pharma Limited's (NSE:BLISSGVS) Stock Up Recently?

How Is Bliss GVS Pharma's (NSE:BLISSGVS) CEO Paid Relative To Peers?

Dec 26
How Is Bliss GVS Pharma's (NSE:BLISSGVS) CEO Paid Relative To Peers?

Did Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Deserve to Gain 14%?

Dec 13
Did Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Deserve to Gain 14%?

Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?

Nov 30
Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?

Bliss GVS Pharma Limited (NSE:BLISSGVS) Insiders Increased Their Holdings

Nov 18
Bliss GVS Pharma Limited (NSE:BLISSGVS) Insiders Increased Their Holdings

Does Bliss GVS Pharma Limited (NSE:BLISSGVS) Have A Place In Your Dividend Portfolio?

Nov 06
Does Bliss GVS Pharma Limited (NSE:BLISSGVS) Have A Place In Your Dividend Portfolio?

Is Bliss GVS Pharma (NSE:BLISSGVS) A Risky Investment?

Oct 25
Is Bliss GVS Pharma (NSE:BLISSGVS) A Risky Investment?

Is Bliss GVS Pharma Limited's (NSE:BLISSGVS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Oct 07
Is Bliss GVS Pharma Limited's (NSE:BLISSGVS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

How Much Is Bliss GVS Pharma Limited (NSE:BLISSGVS) CEO Getting Paid?

Sep 19
How Much Is Bliss GVS Pharma Limited (NSE:BLISSGVS) CEO Getting Paid?

What Is The Ownership Structure Like For Bliss GVS Pharma Limited (NSE:BLISSGVS)?

Sep 04
What Is The Ownership Structure Like For Bliss GVS Pharma Limited (NSE:BLISSGVS)?

Have Insiders Been Buying Bliss GVS Pharma Limited (NSE:BLISSGVS) Shares?

Aug 17
Have Insiders Been Buying Bliss GVS Pharma Limited (NSE:BLISSGVS) Shares?

The Bliss GVS Pharma (NSE:BLISSGVS) Share Price Has Gained 43% And Shareholders Are Hoping For More

Aug 04
The Bliss GVS Pharma (NSE:BLISSGVS) Share Price Has Gained 43% And Shareholders Are Hoping For More

Fewer Investors Than Expected Jumping On Bliss GVS Pharma Limited (NSE:BLISSGVS)

Aug 04
Fewer Investors Than Expected Jumping On Bliss GVS Pharma Limited (NSE:BLISSGVS)

Bliss GVS Pharma (NSE:BLISSGVS) Seems To Use Debt Quite Sensibly

Jul 21
Bliss GVS Pharma (NSE:BLISSGVS) Seems To Use Debt Quite Sensibly

Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?

Jul 06
Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?

CEO Compensation Analysis

How has Gagan Sharma's remuneration changed compared to Bliss GVS Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

₹879m

Sep 30 2023n/an/a

₹883m

Jun 30 2023n/an/a

₹598m

Mar 31 2023₹18m₹18m

₹709m

Dec 31 2022n/an/a

₹871m

Sep 30 2022n/an/a

₹91m

Jun 30 2022n/an/a

₹165m

Mar 31 2022₹15m₹15m

₹150m

Dec 31 2021n/an/a

₹17m

Sep 30 2021n/an/a

₹773m

Jun 30 2021n/an/a

₹766m

Mar 31 2021₹1m₹1m

₹685m

Compensation vs Market: Gagan's total compensation ($USD216.23K) is about average for companies of similar size in the Indian market ($USD186.77K).

Compensation vs Earnings: Gagan's compensation has increased by more than 20% in the past year.


CEO

Gagan Sharma (40 yo)

2.9yrs

Tenure

₹18,032,817

Compensation

Mr. Gagan Harsh Sharma serves as Managing Director at Bliss GVS Pharma Limited since May 11, 2021 and its Director since January 21, 2021. He served as Vice President of Strategy and Business Development a...


Leadership Team

NamePositionTenureCompensationOwnership
Gagan Sharma
MD & Director2.9yrs₹18.03mno data
Deepak Sawant
Chief Financial Officer1.3yrs₹1.63mno data
Aditi Bhatt
Compliance Officer5.7yrs₹1.55mno data
Vibha Sharma
Executive & Whole Time Directorno data₹7.05m2.36%
₹ 303.4m
Shruti Vishal Rao
Executive & Whole Time Directorno data₹6.73m2.02%
₹ 258.7m

2.9yrs

Average Tenure

40yo

Average Age

Experienced Management: BLISSGVS's management team is considered experienced (2.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Gagan Sharma
MD & Director3.3yrs₹18.03mno data
Vibha Sharma
Executive & Whole Time Director15.8yrs₹7.05m2.36%
₹ 303.4m
Shruti Vishal Rao
Executive & Whole Time Director17.8yrs₹6.73m2.02%
₹ 258.7m
Subramanian Vaidya
Independent Chairman of the Board12.8yrs₹375.00kno data
Shilpa Bhatia
Independent Women Director4.2yrs₹375.00kno data
Santosh Parab
Independent Non-Executive Director7.9yrs₹375.00k0.0022%
₹ 282.4k

10.3yrs

Average Tenure

44.5yo

Average Age

Experienced Board: BLISSGVS's board of directors are seasoned and experienced ( 10.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.